CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Current assets
Cash	$ 305	$ 1,341
Other current assets	398	97
Total current assets	703	1,438
Patent license rights, net	0	39
Total assets	703	1,477
Current liabilities
Accounts payable	797	245
Other accrued liabilities	22	1
Total current liabilities	819	246
Secured debt and accrued interest, net of unamortized issuance costs	2,644	2,475
Capstone Therapeutics Corp. Stockholders' Equity
Common Stock $.0005 par value; 150,000,000 shares authorized; 54,385,411 shares outstanding in 2019 and 2018	27	27
Additional paid-in capital	190,490	190,483
Accumulated deficit	(193,277)	(191,754)
Total Capstone Therapeutics Corp. stockholders' equity (deficit)	(2,760)	(1,244)
Noncontrolling interest	0	0
Total equity	(2,760)	(1,244)
Total liabilities and equity	$ 703	$ 1,477

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).